JamesBMartelMDMPH FACS

Clinical Trials

• Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery Start of enrollment: 2008 Jun 01

  Completed

  Phase 3

• Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis Start of enrollment: 2011 Oct 01

  Completed

  Phase 3

• Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis Start of enrollment: 2013 Feb 01

  Terminated

  Phase 3

• Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease) Start of enrollment: 2013 May 17

  Completed

  Phase 2

• Nepafenac Once Daily for Macular Edema - Study 1 Start of enrollment: 2013 Jun 01

  Completed

  Phase 3

• Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia Start of enrollment: 2014 Jul 01

  Completed

  Phase 2

• Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension Start of enrollment: 2014 Dec 15

  Completed

  Phase 3

• Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis Start of enrollment: 2015 May 01

  Completed

  Phase 3

• Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis Start of enrollment: 2015 May 01

  Completed

  Phase 3

• Clinical Evaluation Following Use of SYSTANE® ULTRA in the Management of Dry Eye Start of enrollment: 2015 Jun 19

  Completed

  Not Applicable

• 24-hr Intraocular Pressure Control With SIMBRINZA ® Start of enrollment: 2016 May 23

  Completed

  Phase 4

• Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain Start of enrollment: 2016 Jun 01

  Completed

  Phase 3

• Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye Start of enrollment: 2016 Sep 30

  Terminated

  Phase 3

• Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease Start of enrollment: 2016 Jun 01

  Completed

  Phase 3

• Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME) Start of enrollment: 2016 Aug 24

  Completed

  Phase 1, Phase 2

• Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease Start of enrollment: 2016 Oct 01

  Completed

  Phase 3

• Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo Start of enrollment: 2017 Mar 28

  Terminated

  Phase 3

• Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo Start of enrollment: 2017 Mar 29

  Completed

  Phase 3

• Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome Start of enrollment: 2017 Jun 30

  Completed

  Phase 1, Phase 2

• Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion Start of enrollment: 2017 Jul 31

  Completed

  Phase 3

• Join now to see all